{"organizations": [], "uuid": "168497cb8b647a6bad0a8363e3d7c8648d55cad8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180205.html", "section_title": "Archive News &amp; Video for Monday, 05 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shield-therapeutics-says-top-line/brief-shield-therapeutics-says-top-line-results-from-aegis-ckd-pivotal-phase-iii-study-of-feraccru-idUSFWN1PV0BB", "country": "US", "domain_rank": 408, "title": "BRIEF-Shield Therapeutics Says Top-Line Results From Aegis-Ckd Pivotal Phase III Study Of Feraccru​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.573, "site_type": "news", "published": "2018-02-05T15:24:00.000+02:00", "replies_count": 0, "uuid": "168497cb8b647a6bad0a8363e3d7c8648d55cad8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shield-therapeutics-says-top-line/brief-shield-therapeutics-says-top-line-results-from-aegis-ckd-pivotal-phase-iii-study-of-feraccru-idUSFWN1PV0BB", "ord_in_thread": 0, "title": "BRIEF-Shield Therapeutics Says Top-Line Results From Aegis-Ckd Pivotal Phase III Study Of Feraccru​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 5 (Reuters) - Shield Therapeutics Plc:\n* ‍ANNOUNCES TOP-LINE RESULTS FROM ITS AEGIS-CKD PIVOTAL PHASE III STUDY OF FERACCRU​\n* ‍PRIMARY EFFICACY ENDPOINT NOT ACHIEVED​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-05T15:24:00.000+02:00", "crawled": "2018-02-06T23:52:48.018+02:00", "highlightTitle": ""}